Clinical Institute, Aalborg University, Fredrik Bajers vej 7, 9220, Aalborg, Denmark,
Osteoporos Int. 2014 Jun;25(6):1697-708. doi: 10.1007/s00198-014-2676-7. Epub 2014 Mar 28.
This study examined whether markers of bone turnover differ between individuals with and without diabetes. Bone markers showed heterogeneity between studies and were discrepant for markers of bone creation and markers of bone degradation. Bone markers may be of lesser value in diabetes due to heterogeneity.
The aim of this meta-analysis was to compare existing literature regarding changes in bone markers among diabetics compared to healthy controls. To exclude that blood glucose levels among diabetes patients could influence the assays used for determining bone turnover markers, a methodological study was performed.
Medline at Pubmed Embase, Cinahl, Svemed+, Cochrane library, and Bibliotek.dk was searched in August 2012. The studies should examine biochemical bone turnover among diabetes patients in comparison to controls in an observational design. In the methodological study, fasting blood samples were drawn from two individuals. Glucose was added to the blood samples in different concentrations and OC, CTX, and procollagen type 1 amino terminal propeptide were measured after 0, 1, 2, and 3 h.
Twenty-two papers fulfilled the criteria for the meta-analysis. From the pooled data in the meta-analysis, the bone markers osteocalcin (OC) (-1.15 ng/ml [-1.78,-0.52]) and C-terminal cross-linked telopeptide (CTX) (-0.14 ng/ml [-0.22, -0.05]) were significantly lower among diabetes patients than non-diabetes patients, however other markers did not differ. All markers displayed very high heterogeneity by I2 statistics. In the methodological study, the addition of glucose did not significantly change the bone markers neither by level of glucose nor with increasing incubation time.
The dissociative pattern of biochemical bone markers of bone formation and bone resorption present in diabetes patients is thus not caused by glucose per se but may be modulated by unknown factors associated with diabetes mellitus.
本研究旨在比较糖尿病患者和健康对照组之间骨转换标志物的差异。为了排除糖尿病患者的血糖水平可能影响用于确定骨转换标志物的检测方法,我们进行了一项方法学研究。
我们于 2012 年 8 月检索了 Medline 上的 Pubmed、Embase、Cinahl、Svemed+、Cochrane 图书馆和 Bibliotek.dk。研究应在观察性设计中比较糖尿病患者和对照组之间的生化骨转换标志物。在方法学研究中,我们从两个人身上抽取空腹血样。向血液样本中添加不同浓度的葡萄糖,然后在 0、1、2 和 3 小时后测量 OC、CTX 和前胶原 1 氨基端前肽。
22 篇论文符合荟萃分析的标准。从荟萃分析的汇总数据中,我们发现骨标志物骨钙素(OC)(-1.15ng/ml[-1.78,-0.52])和 C 端交联肽(CTX)(-0.14ng/ml[-0.22,-0.05])在糖尿病患者中明显低于非糖尿病患者,但其他标志物没有差异。所有标志物的 I2 统计数据显示出非常高的异质性。在方法学研究中,葡萄糖的添加并没有显著改变骨标志物,无论是葡萄糖的水平还是随着孵育时间的增加。
糖尿病患者中骨形成和骨吸收的生化骨标志物的分离模式不是由葡萄糖本身引起的,而是可能被与糖尿病相关的未知因素所调节。